Grajek, S.; Kałużna-Oleksy, M.; Siller-Matula, J.M.; Grajek, M.; Michalak, M.
Non-Vitamin K Antagonist Oral Anticoagulants and Risk of Myocardial Infarction in Patients with Atrial Fibrillation with or without Percutaneous Coronary Interventions: A Meta-Analysis. J. Pers. Med. 2021, 11, 1013.
https://doi.org/10.3390/jpm11101013
AMA Style
Grajek S, Kałużna-Oleksy M, Siller-Matula JM, Grajek M, Michalak M.
Non-Vitamin K Antagonist Oral Anticoagulants and Risk of Myocardial Infarction in Patients with Atrial Fibrillation with or without Percutaneous Coronary Interventions: A Meta-Analysis. Journal of Personalized Medicine. 2021; 11(10):1013.
https://doi.org/10.3390/jpm11101013
Chicago/Turabian Style
Grajek, Stefan, Marta Kałużna-Oleksy, Jolanta M. Siller-Matula, Maksymilian Grajek, and Michał Michalak.
2021. "Non-Vitamin K Antagonist Oral Anticoagulants and Risk of Myocardial Infarction in Patients with Atrial Fibrillation with or without Percutaneous Coronary Interventions: A Meta-Analysis" Journal of Personalized Medicine 11, no. 10: 1013.
https://doi.org/10.3390/jpm11101013
APA Style
Grajek, S., Kałużna-Oleksy, M., Siller-Matula, J. M., Grajek, M., & Michalak, M.
(2021). Non-Vitamin K Antagonist Oral Anticoagulants and Risk of Myocardial Infarction in Patients with Atrial Fibrillation with or without Percutaneous Coronary Interventions: A Meta-Analysis. Journal of Personalized Medicine, 11(10), 1013.
https://doi.org/10.3390/jpm11101013
